Table of Content

1 Transdermal Skin Patch Market Overview
1.1 Product Overview and Scope of Transdermal Skin Patch
1.2 Transdermal Skin Patch Segment by Type
1.2.1 Global Transdermal Skin Patch Market Value Comparison by Type (2024-2034)
1.2.2 Fentanyl Transdermal Skin Patch
1.2.3 Nicotine Transdermal Skin Patch
1.2.4 Clonidine Transdermal Skin Patch
1.2.5 Buprenorphine Transdermal Skin Patch
1.3 Transdermal Skin Patch Segment by Application
1.3.1 Global Transdermal Skin Patch Market Value by Application: (2024-2034)
1.3.2 Relieve Severe Pain
1.3.3 Stop Smoking Cigarettes
1.3.4 Treat an Overactive Bladder
1.3.5 Others
1.4 Global Transdermal Skin Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Skin Patch Revenue 2018-2034
1.4.2 Global Transdermal Skin Patch Sales 2018-2034
1.4.3 Global Transdermal Skin Patch Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Transdermal Skin Patch Market Competition by Manufacturers
2.1 Global Transdermal Skin Patch Sales Market Share by Manufacturers (2018-2024)
2.2 Global Transdermal Skin Patch Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Transdermal Skin Patch Average Price by Manufacturers (2018-2024)
2.4 Global Transdermal Skin Patch Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Transdermal Skin Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Skin Patch, Product Type & Application
2.7 Transdermal Skin Patch Market Competitive Situation and Trends
2.7.1 Transdermal Skin Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Skin Patch Players Market Share by Revenue
2.7.3 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Skin Patch Retrospective Market Scenario by Region
3.1 Global Transdermal Skin Patch Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Transdermal Skin Patch Global Transdermal Skin Patch Sales by Region: 2018-2034
3.2.1 Global Transdermal Skin Patch Sales by Region: 2018-2024
3.2.2 Global Transdermal Skin Patch Sales by Region: 2024-2034
3.3 Global Transdermal Skin Patch Global Transdermal Skin Patch Revenue by Region: 2018-2034
3.3.1 Global Transdermal Skin Patch Revenue by Region: 2018-2024
3.3.2 Global Transdermal Skin Patch Revenue by Region: 2024-2034
3.4 North America Transdermal Skin Patch Market Facts & Figures by Country
3.4.1 North America Transdermal Skin Patch Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Transdermal Skin Patch Sales by Country (2018-2034)
3.4.3 North America Transdermal Skin Patch Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal Skin Patch Market Facts & Figures by Country
3.5.1 Europe Transdermal Skin Patch Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Transdermal Skin Patch Sales by Country (2018-2034)
3.5.3 Europe Transdermal Skin Patch Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Skin Patch Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Transdermal Skin Patch Sales by Country (2018-2034)
3.6.3 Asia Pacific Transdermal Skin Patch Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transdermal Skin Patch Market Facts & Figures by Country
3.7.1 Latin America Transdermal Skin Patch Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Transdermal Skin Patch Sales by Country (2018-2034)
3.7.3 Latin America Transdermal Skin Patch Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Skin Patch Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Transdermal Skin Patch Sales by Country (2018-2034)
3.8.3 Middle East and Africa Transdermal Skin Patch Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Transdermal Skin Patch Sales by Type (2018-2034)
4.1.1 Global Transdermal Skin Patch Sales by Type (2018-2024)
4.1.2 Global Transdermal Skin Patch Sales by Type (2024-2034)
4.1.3 Global Transdermal Skin Patch Sales Market Share by Type (2018-2034)
4.2 Global Transdermal Skin Patch Revenue by Type (2018-2034)
4.2.1 Global Transdermal Skin Patch Revenue by Type (2018-2024)
4.2.2 Global Transdermal Skin Patch Revenue by Type (2024-2034)
4.2.3 Global Transdermal Skin Patch Revenue Market Share by Type (2018-2034)
4.3 Global Transdermal Skin Patch Price by Type (2018-2034)
5 Segment by Application
5.1 Global Transdermal Skin Patch Sales by Application (2018-2034)
5.1.1 Global Transdermal Skin Patch Sales by Application (2018-2024)
5.1.2 Global Transdermal Skin Patch Sales by Application (2024-2034)
5.1.3 Global Transdermal Skin Patch Sales Market Share by Application (2018-2034)
5.2 Global Transdermal Skin Patch Revenue by Application (2018-2034)
5.2.1 Global Transdermal Skin Patch Revenue by Application (2018-2024)
5.2.2 Global Transdermal Skin Patch Revenue by Application (2024-2034)
5.2.3 Global Transdermal Skin Patch Revenue Market Share by Application (2018-2034)
5.3 Global Transdermal Skin Patch Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Novartis Transdermal Skin Patch Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Teikoku Pharma
6.4.1 Teikoku Pharma Corporation Information
6.4.2 Teikoku Pharma Description and Business Overview
6.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
6.4.5 Teikoku Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Mylan Transdermal Skin Patch Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Actavis
6.6.1 Actavis Corporation Information
6.6.2 Actavis Description and Business Overview
6.6.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Actavis Transdermal Skin Patch Product Portfolio
6.6.5 Actavis Recent Developments/Updates
6.7 Mundipharma
6.6.1 Mundipharma Corporation Information
6.6.2 Mundipharma Description and Business Overview
6.6.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Mundipharma Transdermal Skin Patch Product Portfolio
6.7.5 Mundipharma Recent Developments/Updates
6.8 Henan Lingrui Pharmaceutical
6.8.1 Henan Lingrui Pharmaceutical Corporation Information
6.8.2 Henan Lingrui Pharmaceutical Description and Business Overview
6.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
6.8.5 Henan Lingrui Pharmaceutical Recent Developments/Updates
6.9 Changzhou Siyao
6.9.1 Changzhou Siyao Corporation Information
6.9.2 Changzhou Siyao Description and Business Overview
6.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
6.9.5 Changzhou Siyao Recent Developments/Updates
6.10 Rfl Pharmaceutical
6.10.1 Rfl Pharmaceutical Corporation Information
6.10.2 Rfl Pharmaceutical Description and Business Overview
6.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
6.10.5 Rfl Pharmaceutical Recent Developments/Updates
6.11 Luye Pharma Group Ltd.
6.11.1 Luye Pharma Group Ltd. Corporation Information
6.11.2 Luye Pharma Group Ltd. Transdermal Skin Patch Description and Business Overview
6.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
6.11.5 Luye Pharma Group Ltd. Recent Developments/Updates
6.12 Purdue Pharma L.P.
6.12.1 Purdue Pharma L.P. Corporation Information
6.12.2 Purdue Pharma L.P. Transdermal Skin Patch Description and Business Overview
6.12.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
6.12.5 Purdue Pharma L.P. Recent Developments/Updates
6.13 Teva Pharmaceutical Industries Ltd.
6.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.13.2 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Description and Business Overview
6.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
6.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Skin Patch Industry Chain Analysis
7.2 Transdermal Skin Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Skin Patch Production Mode & Process
7.4 Transdermal Skin Patch Sales and Marketing
7.4.1 Transdermal Skin Patch Sales Channels
7.4.2 Transdermal Skin Patch Distributors
7.5 Transdermal Skin Patch Customers
8 Transdermal Skin Patch Market Dynamics
8.1 Transdermal Skin Patch Industry Trends
8.2 Transdermal Skin Patch Market Drivers
8.3 Transdermal Skin Patch Market Challenges
8.4 Transdermal Skin Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Transdermal Skin Patch Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Transdermal Skin Patch Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Transdermal Skin Patch Market Competitive Situation by Manufacturers in 2022
Table 4. Global Transdermal Skin Patch Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Transdermal Skin Patch Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Transdermal Skin Patch Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Transdermal Skin Patch Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Transdermal Skin Patch Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Transdermal Skin Patch, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Transdermal Skin Patch, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Transdermal Skin Patch, Product Type & Application
Table 12. Global Key Manufacturers of Transdermal Skin Patch, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Skin Patch as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Transdermal Skin Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Transdermal Skin Patch Sales by Region (2018-2024) & (K Units)
Table 18. Global Transdermal Skin Patch Sales Market Share by Region (2018-2024)
Table 19. Global Transdermal Skin Patch Sales by Region (2024-2034) & (K Units)
Table 20. Global Transdermal Skin Patch Sales Market Share by Region (2024-2034)
Table 21. Global Transdermal Skin Patch Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Transdermal Skin Patch Revenue Market Share by Region (2018-2024)
Table 23. Global Transdermal Skin Patch Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Transdermal Skin Patch Revenue Market Share by Region (2024-2034)
Table 25. North America Transdermal Skin Patch Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Transdermal Skin Patch Sales by Country (2018-2024) & (K Units)
Table 27. North America Transdermal Skin Patch Sales by Country (2024-2034) & (K Units)
Table 28. North America Transdermal Skin Patch Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Transdermal Skin Patch Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Transdermal Skin Patch Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Transdermal Skin Patch Sales by Country (2018-2024) & (K Units)
Table 32. Europe Transdermal Skin Patch Sales by Country (2024-2034) & (K Units)
Table 33. Europe Transdermal Skin Patch Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Transdermal Skin Patch Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Transdermal Skin Patch Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Transdermal Skin Patch Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Transdermal Skin Patch Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Transdermal Skin Patch Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Transdermal Skin Patch Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Transdermal Skin Patch Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Transdermal Skin Patch Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Transdermal Skin Patch Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Transdermal Skin Patch Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Transdermal Skin Patch Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Transdermal Skin Patch Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Transdermal Skin Patch Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Transdermal Skin Patch Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Transdermal Skin Patch Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Transdermal Skin Patch Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Transdermal Skin Patch Sales (K Units) by Type (2018-2024)
Table 51. Global Transdermal Skin Patch Sales (K Units) by Type (2024-2034)
Table 52. Global Transdermal Skin Patch Sales Market Share by Type (2018-2024)
Table 53. Global Transdermal Skin Patch Sales Market Share by Type (2024-2034)
Table 54. Global Transdermal Skin Patch Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Transdermal Skin Patch Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Transdermal Skin Patch Revenue Market Share by Type (2018-2024)
Table 57. Global Transdermal Skin Patch Revenue Market Share by Type (2024-2034)
Table 58. Global Transdermal Skin Patch Price (USD/Unit) by Type (2018-2024)
Table 59. Global Transdermal Skin Patch Price (USD/Unit) by Type (2024-2034)
Table 60. Global Transdermal Skin Patch Sales (K Units) by Application (2018-2024)
Table 61. Global Transdermal Skin Patch Sales (K Units) by Application (2024-2034)
Table 62. Global Transdermal Skin Patch Sales Market Share by Application (2018-2024)
Table 63. Global Transdermal Skin Patch Sales Market Share by Application (2024-2034)
Table 64. Global Transdermal Skin Patch Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Transdermal Skin Patch Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Transdermal Skin Patch Revenue Market Share by Application (2018-2024)
Table 67. Global Transdermal Skin Patch Revenue Market Share by Application (2024-2034)
Table 68. Global Transdermal Skin Patch Price (USD/Unit) by Application (2018-2024)
Table 69. Global Transdermal Skin Patch Price (USD/Unit) by Application (2024-2034)
Table 70. Hisamitsu Pharmaceutical Corporation Information
Table 71. Hisamitsu Pharmaceutical Description and Business Overview
Table 72. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Hisamitsu Pharmaceutical Transdermal Skin Patch Product
Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Novartis Transdermal Skin Patch Product
Table 79. Novartis Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Johnson & Johnson Transdermal Skin Patch Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Teikoku Pharma Corporation Information
Table 86. Teikoku Pharma Description and Business Overview
Table 87. Teikoku Pharma Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Teikoku Pharma Transdermal Skin Patch Product
Table 89. Teikoku Pharma Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Mylan Transdermal Skin Patch Product
Table 94. Mylan Recent Developments/Updates
Table 95. Actavis Corporation Information
Table 96. Actavis Description and Business Overview
Table 97. Actavis Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Actavis Transdermal Skin Patch Product
Table 99. Actavis Recent Developments/Updates
Table 100. Mundipharma Corporation Information
Table 101. Mundipharma Description and Business Overview
Table 102. Mundipharma Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Mundipharma Transdermal Skin Patch Product
Table 104. Mundipharma Recent Developments/Updates
Table 105. Henan Lingrui Pharmaceutical Corporation Information
Table 106. Henan Lingrui Pharmaceutical Description and Business Overview
Table 107. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product
Table 109. Henan Lingrui Pharmaceutical Recent Developments/Updates
Table 110. Changzhou Siyao Corporation Information
Table 111. Changzhou Siyao Description and Business Overview
Table 112. Changzhou Siyao Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Changzhou Siyao Transdermal Skin Patch Product
Table 114. Changzhou Siyao Recent Developments/Updates
Table 115. Rfl Pharmaceutical Corporation Information
Table 116. Rfl Pharmaceutical Description and Business Overview
Table 117. Rfl Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Rfl Pharmaceutical Transdermal Skin Patch Product
Table 119. Rfl Pharmaceutical Recent Developments/Updates
Table 120. Luye Pharma Group Ltd. Corporation Information
Table 121. Luye Pharma Group Ltd. Description and Business Overview
Table 122. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Luye Pharma Group Ltd. Transdermal Skin Patch Product
Table 124. Luye Pharma Group Ltd. Recent Developments/Updates
Table 125. Purdue Pharma L.P. Corporation Information
Table 126. Purdue Pharma L.P. Description and Business Overview
Table 127. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Purdue Pharma L.P. Transdermal Skin Patch Product
Table 129. Purdue Pharma L.P. Recent Developments/Updates
Table 130. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 131. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 132. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product
Table 134. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Transdermal Skin Patch Distributors List
Table 138. Transdermal Skin Patch Customers List
Table 139. Transdermal Skin Patch Market Trends
Table 140. Transdermal Skin Patch Market Drivers
Table 141. Transdermal Skin Patch Market Challenges
Table 142. Transdermal Skin Patch Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Transdermal Skin Patch
Figure 2. Global Transdermal Skin Patch Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Transdermal Skin Patch Market Share by Type in 2022 & 2034
Figure 4. Fentanyl Transdermal Skin Patch Product Picture
Figure 5. Nicotine Transdermal Skin Patch Product Picture
Figure 6. Clonidine Transdermal Skin Patch Product Picture
Figure 7. Buprenorphine Transdermal Skin Patch Product Picture
Figure 8. Global Transdermal Skin Patch Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Transdermal Skin Patch Market Share by Application in 2022 & 2034
Figure 10. Relieve Severe Pain
Figure 11. Stop Smoking Cigarettes
Figure 12. Treat an Overactive Bladder
Figure 13. Others
Figure 14. Global Transdermal Skin Patch Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Transdermal Skin Patch Market Size (2018-2034) & (US$ Million)
Figure 16. Global Transdermal Skin Patch Sales (2018-2034) & (K Units)
Figure 17. Global Transdermal Skin Patch Average Price (USD/Unit) & (2018-2034)
Figure 18. Transdermal Skin Patch Report Years Considered
Figure 19. Transdermal Skin Patch Sales Share by Manufacturers in 2022
Figure 20. Global Transdermal Skin Patch Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Transdermal Skin Patch Players: Market Share by Revenue in 2022
Figure 22. Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Transdermal Skin Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 24. North America Transdermal Skin Patch Sales Market Share by Country (2018-2034)
Figure 25. North America Transdermal Skin Patch Revenue Market Share by Country (2018-2034)
Figure 26. U.S. Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Transdermal Skin Patch Sales Market Share by Country (2018-2034)
Figure 29. Europe Transdermal Skin Patch Revenue Market Share by Country (2018-2034)
Figure 30. Germany Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Transdermal Skin Patch Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region (2018-2034)
Figure 37. China Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Taiwan Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Philippines Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Transdermal Skin Patch Sales Market Share by Country (2018-2034)
Figure 48. Latin America Transdermal Skin Patch Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Transdermal Skin Patch Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Transdermal Skin Patch Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. U.A.E Transdermal Skin Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Transdermal Skin Patch by Type (2018-2034)
Figure 58. Global Revenue Market Share of Transdermal Skin Patch by Type (2018-2034)
Figure 59. Global Transdermal Skin Patch Price (USD/Unit) by Type (2018-2034)
Figure 60. Global Sales Market Share of Transdermal Skin Patch by Application (2018-2034)
Figure 61. Global Revenue Market Share of Transdermal Skin Patch by Application (2018-2034)
Figure 62. Global Transdermal Skin Patch Price (USD/Unit) by Application (2018-2034)
Figure 63. Transdermal Skin Patch Value Chain
Figure 64. Transdermal Skin Patch Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed